Glycine

Glycine

SCHEMBL4940394

NCC(=O)O.[Ca+2].[OH-].[OH-]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADORA1ADORA2AADORA2BADORA3PDE3APDE3BPDE4APDE4BPDE4CPDE4D

The experimentally established mechanism targets of Glycine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Glycine SCHEMBL2916898 0.96
Glycine SCHEMBL19100314 0.96 GLRA1 (0.91)
Glycine SCHEMBL29262735 0.92 GLRA1 (0.83)
Glycine SCHEMBL3863155 0.92
Glycine SCHEMBL28348053 0.92
Glycine SCHEMBL5068687 0.92
Glycine SCHEMBL5163283 0.92 GLRA1 (0.83)
Glycine SCHEMBL7756500 0.92 GLRA1 (0.83)
Glycine SCHEMBL54771 0.92
Glycine SCHEMBL29749211 0.92

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080146641-A1 ANTIBACTERIAL COMPOSITION URANO TERUO 2008-06-19 US disclosed
US-20040127535-A1 containing either a calcium oxide or calcium hydroxide alpha -amino acid chelate compound or both MURAKASHI LIME INDUSTRY CO., LTD. (JP) 2004-07-01 US disclosed